Levetiracetam is safe and effective as an initial monotherapy in childhood epileptic disorders, especially idiopathic epilepsy.
The efficacy of levetiracetam was independent of the seizure semiology, gender, and age.
The efficacy of levetiracetam was similar at the 3rd and 12th months of treatment.